TY  - SER
AU  - Zamay,Tatiana N.
AU  - Zamay,Galina S.
AU  - Babkin,Vasily A.
AU  - Medvedeva,Elena N.
AU  - Neverova,Nadezhda A.
AU  - Kirichenko,Andrey K.
AU  - Zamay,Sergey S.
AU  - Lapin,Ivan N.
AU  - Morozov,Evgeny V.
AU  - Kolovskaya,Olga S.
AU  - Sokolov,Alexey E.
AU  - Narodov,Andrey A.
AU  - Fedorov,Dmitri G.
AU  - Tomilin,Felix N.
AU  - Zabluda,Vladimir N.
AU  - Svetlichnyi,Valerii A.
TI  - Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer
KW  - аптамеры
KW  - арабиногалактан
KW  - ферроарабиногалактан
KW  - магнитодинамическая терапия
KW  - магнитно-резонансная томография
KW  - суперпарамагнитные наночастицы
KW  - таргетная терапия
KW  - онкология
KW  - статьи в журналах
N1  - Библиогр.: 46 назв
N2  - Nanotechnologies involving physical methods of tumor destruction using functional oligonucleotides are promising for targeted cancer therapy. Our study presents magnetodynamic therapy for selective elimination of tumor cells in vivo using DNA aptamer-functionalized magnetic nanoparticles exposed to a low frequency alternating magnetic field. We developed an enhanced targeting approach of cancer cells with aptamers and arabinogalactan. Aptamers to fibronectin (AS-14) and heat shock cognate 71 kDa protein (AS-42) facilitated the delivery of the nanoparticles to Ehrlich carcinoma cells, and arabinogalactan (AG) promoted internalization through asialoglycoprotein receptors. Specific delivery of the aptamer-modified FeAG nanoparticles to the tumor site was confirmed by magnetic resonance imaging (MRI). After the following treatment with a low frequency alternating magnetic field, AS-FeAG caused cancer cell death in vitro and tumor reduction in vivo. Histological analyses showed mechanical disruption of tumor tissues, total necrosis, cell lysis, and disruption of the extracellular matrix. The enhanced targeted magnetic theranostics with the aptamer conjugated superparamagnetic ferroarabinogalactans opens up a new venue for making biocompatible contrasting agents for MRI imaging and performing non-invasive anti-cancer therapies with a deep penetrated magnetic field
UR  - http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000794300
ER  -